Comments: IL SB1842 | 2021-2022 | 102nd General Assembly

Bill Title: Amends the Illinois Controlled Substances Act. Provides that when a person has been identified as having 5 (rather than 3) or more prescribers or 5 (rather than 3) or more pharmacies, or both, that do not utilize a common electronic file for controlled substances within the course of a 6-month (rather than continuous 30-day) period, the Prescription Monitoring Program may issue an unsolicited report to the prescribers, dispensers, and their designees informing them of the potential medication shopping. Provides that specified requirements also apply to opioid treatment programs that are licensed or certified by the Department of Human Services' Division of Substance Use Prevention and Recovery and are authorized by the federal Drug Enforcement Administration to prescribe Schedule II, III, IV, or V controlled substances for the treatment of opioid use disorders. Requires opioid treatment programs to attempt to obtain written patient consent, document attempts to obtain the written consent, and not transmit information without patient consent. Provides that the documentation obtained shall not be utilized for law enforcement purposes. Provides that treatment of a patient shall not be conditioned upon his or her written consent. Makes other changes. Effective immediately.

Spectrum: Partisan Bill (Democrat 4-0)

Status: (Passed) 2021-08-20 - Public Act . . . . . . . . . 102-0527 [SB1842 Detail]

Text: Latest bill text (Chaptered) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2021 Illinois SB1842 at this time.

Social Comments on IL SB1842

feedback